Dilution of share value through the exercise of stock acquisition rights
First written in FY2023. 7 of 8 entries say "Materialised", first in FY2024-Q1. Latest entry: FY2026.
Axis Consulting moved to the "Worse" side of this theme in 2023, 2 years after the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
56 other companies' latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares from stock acquisition rights was 27,220, equivalent to 0.5% of the combined total of 5,089,270 issued shares and potential shares.」
Although 12,900 shares were issued during the fiscal year through the exercise of stock acquisition rights, potential shares at the end of the period declined to 27,220, and potential shares as a percentage of total shares declined to 0.5%. - FY2026-H1MaterialisedAnnual report
「1 July 2025–31 December 2025: 8,280; 5,057,430; 0; 762; 0; 744. Note: increase due to exercise of stock acquisition rights.」
Exercise resulted in 8,280 shares being issued during the interim accounting period. A further increase of 390 shares was disclosed in January 2026. - FY2025MaterialisedAnnual report
「1 July 2024–30 June 2025: 56,550; 5,049,150; 2; 761; 2; 743. Note: increase due to exercise of stock acquisition rights.」
Exercise resulted in 56,550 shares being issued during the fiscal year. Potential shares at year-end were 41,620, or 0.8% of issued and potential shares. - FY2024MaterialisedAnnual report
「Increase due to exercise of stock acquisition rights: 73,200 shares.」
A total of 73,200 shares were issued through exercise during the consolidated fiscal year. Potential shares at year-end were 100,980, or 2.0% of issued and potential shares. - FY2024-Q3MaterialisedAnnual report
「1 January 2024–31 March 2024: 4,230; 4,992,000; 743; 758,937; 738; 740,929. Note: increase due to exercise of stock acquisition rights.」
Exercise of stock acquisition rights resulted in 4,230 shares being issued during the third quarter. - FY2024-Q2MaterialisedAnnual report
「1 October 2023–31 December 2023: 65,310; 4,987,770; 3,348; 758,194; 3,347; 740,191. Note: increase due to exercise of stock acquisition rights.」
Exercise of stock acquisition rights resulted in 65,310 shares being issued during the second quarter, creating actual dilution. - FY2024-Q1MaterialisedAnnual report
「Increase in total issued shares: 3,060 shares, due to the exercise of stock acquisition rights. Between 1 October and 31 October 2023, exercise of stock acquisition rights increased issued shares by 29,550, capital by ¥1.560 million and capital surplus by ¥1.559 million.」
Exercise resulted in 3,060 shares during the quarter and 29,550 shares in October 2023 before filing, demonstrating actual dilution-related exercises. - FY2023First statedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares from stock acquisition rights was 159,510, equivalent to 3.1% of the total of 5,078,910 issued and potential shares.」
The possibility of exercise within several years and dilution from potential shares representing 3.1% is disclosed for stock acquisition rights granted to directors and employees.